Kala Bio Inc (KALA)
6.43
+0.25
(+4.05%)
USD |
NASDAQ |
Apr 26, 16:00
6.43
0.00 (0.00%)
After-Hours: 20:00
Kala Bio Cash from Investing (TTM): -0.429M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.429M |
September 30, 2023 | -0.371M |
June 30, 2023 | 54.82M |
March 31, 2023 | 67.68M |
December 31, 2022 | 62.72M |
September 30, 2022 | 58.04M |
June 30, 2022 | -2.147M |
March 31, 2022 | 17.70M |
December 31, 2021 | 70.80M |
September 30, 2021 | 112.27M |
June 30, 2021 | 49.95M |
March 31, 2021 | -29.89M |
December 31, 2020 | -78.21M |
September 30, 2020 | -115.24M |
June 30, 2020 | -57.84M |
Date | Value |
---|---|
March 31, 2020 | -1.183M |
December 31, 2019 | -1.335M |
September 30, 2019 | -2.057M |
June 30, 2019 | -1.98M |
March 31, 2019 | -1.649M |
December 31, 2018 | -1.578M |
September 30, 2018 | -0.95M |
June 30, 2018 | -0.912M |
March 31, 2018 | -0.781M |
December 31, 2017 | -0.48M |
September 30, 2017 | -0.256M |
June 30, 2017 | -0.216M |
March 31, 2017 | -0.225M |
December 31, 2016 | -0.153M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-115.24M
Minimum
Sep 2020
112.27M
Maximum
Sep 2021
10.70M
Average
-0.429M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
CEL-SCI Corp | -0.3835M |
AIM ImmunoTech Inc | -0.832M |
IGC Pharma Inc | -0.236M |
NovaBay Pharmaceuticals Inc | -0.019M |
Protalix BioTherapeutics Inc | -16.71M |